The FGFR1 N546K mutation confers resistance to pemigatinib in MLN-ZMYM2::FGFR1
- DOI
- 10.1038/s41375-026-02890-w
- Published
- 2026-02-20
- Container
- Leukemia
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41375-026-02890-w,
title = {The FGFR1 N546K mutation confers resistance to pemigatinib in MLN-ZMYM2::FGFR1},
author = {Khalid Shoumariyeh and Stefan Haug and Juliana Schwaab and Julie K. Pfeil and Jannis Stappenbeck and Annette Schmitt-Graeff and Nicole Naumann and Greta Waltemode and Robert Zeiser and Cornelius Miething and Wolf-Karsten Hofmann and Manja Meggendorfer and Sven Diederichs and Justus Duyster and Andreas Reiter},
year = {2026},
journal = {Leukemia},
doi = {10.1038/s41375-026-02890-w},
url = {https://doi.org/10.1038/s41375-026-02890-w}
}RIS
TY - JOUR TI - The FGFR1 N546K mutation confers resistance to pemigatinib in MLN-ZMYM2::FGFR1 AU - Khalid Shoumariyeh AU - Stefan Haug AU - Juliana Schwaab AU - Julie K. Pfeil AU - Jannis Stappenbeck AU - Annette Schmitt-Graeff AU - Nicole Naumann AU - Greta Waltemode AU - Robert Zeiser AU - Cornelius Miething AU - Wolf-Karsten Hofmann AU - Manja Meggendorfer AU - Sven Diederichs AU - Justus Duyster AU - Andreas Reiter PY - 2026 JO - Leukemia DO - 10.1038/s41375-026-02890-w UR - https://doi.org/10.1038/s41375-026-02890-w ER -
APA
Shoumariyeh, K., Haug, S., Schwaab, J., Pfeil, J. K., Stappenbeck, J., Schmitt-Graeff, A., Naumann, N., Waltemode, G., Zeiser, R., Miething, C., Hofmann, W., Meggendorfer, M., Diederichs, S., Duyster, J., & Reiter, A. (2026). The FGFR1 N546K mutation confers resistance to pemigatinib in MLN-ZMYM2::FGFR1. Leukemia. https://doi.org/10.1038/s41375-026-02890-w
Source records
- crossref · retrieved 2026-09-26T08:33:53.981Z